This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Worldwide Innovative Network. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Jean-Charles Soria: Innovator in Lung Cancer Treatment
Introduction
Jean-Charles Soria is a prominent inventor based in Igny, France. He has made significant contributions to the field of oncology, particularly in the treatment of lung cancer. His innovative approach focuses on the molecular characterization of tumors to enhance treatment efficacy.
Latest Patents
Soria holds a patent for "Computer implemented methods of treating lung cancer." This invention involves a method for predicting the relative efficacy of various drugs for treating tumors in individuals. The process includes the molecular characterization of the tumor and the calculation of a score for the drugs based on the percentage of deregulated target genes. He has 1 patent to his name.
Career Highlights
Jean-Charles Soria is associated with the Worldwide Innovative Network, where he continues to advance research in cancer treatment. His work is pivotal in developing personalized medicine approaches that cater to individual patient needs.
Collaborations
Soria has collaborated with notable professionals in his field, including Vladimir Lazar and Michel Ducreux. Their combined expertise contributes to the innovative solutions being developed in cancer treatment.
Conclusion
Jean-Charles Soria's work exemplifies the intersection of technology and medicine, particularly in the fight against lung cancer. His contributions are vital for improving treatment outcomes and advancing personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile